financetom
Business
financetom
/
Business
/
Reliance Capital: Lenders invite EOIs stake in key subsidiaries
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Reliance Capital: Lenders invite EOIs stake in key subsidiaries
Nov 2, 2020 6:12 AM

The debenture holders committee has kick started the process to sell several key subsidiaries of Anil Ambani led Reliance Capital over the weekend. CNBC-TV18 learned that the committee has expressions of interest (EoI) for sale in Reliance Capital companies by December 1st.

The lenders have started the process of selling its stake in various of its key subsidiaries in order to recovery dues of almost Rs 20,000 crore. The monetisation process is being run by the committee of debenture holders who alone represent almost 93 percent of the total debt that Reliance Capital has. Bank of Baroda, Axis Bank and other are some of the key bankers that are also involved.

Ritu Singh tracks the story and gets the latest developments.

To know more, watch the video.

(Edited by : Abhishek Jha)

First Published:Nov 2, 2020 3:12 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Alvotech Full-Year 2023 Loss Narrows, Revenue Rises
Alvotech Full-Year 2023 Loss Narrows, Revenue Rises
Mar 20, 2024
04:45 PM EDT, 03/20/2024 (MT Newswires) -- Alvotech ( ALVO ) reported a full-year 2023 loss late Wednesday of $2.43 per diluted share, narrower than a loss of $2.60 a year earlier. Four analysts surveyed by Capital IQ expected a loss of $1.09. Revenue for the year ended Dec. 31 was $93.4 million, up 10% from a year earlier. Analysts...
Guess? Stock Climbs On Q4 Results: EPS Beat, Revenue Beat, Special Cash Dividend
Guess? Stock Climbs On Q4 Results: EPS Beat, Revenue Beat, Special Cash Dividend
Mar 20, 2024
Guess?, Inc. ( GES ) reported its fourth-quarter financial results after the bell Thursday. Here's a look at the highlights. The Details: Guess? reported quarterly earnings of $2.01 per share which beat the analyst consensus estimate of $1.56 by 28.85%. Quarterly sales clocked in at $891.05 million, beating the analyst consensus estimate of $855.54 million by 4.15% and representing an...
Fusion Pharmaceuticals Narrows Q4 Loss; Enters Sale Deal With AstraZeneca
Fusion Pharmaceuticals Narrows Q4 Loss; Enters Sale Deal With AstraZeneca
Mar 20, 2024
04:44 PM EDT, 03/20/2024 (MT Newswires) -- Fusion Pharmaceuticals ( FUSN ) late Wednesday reported a Q4 net loss of $0.39 per diluted share, compared with a $0.55 loss a year earlier. Analysts polled by Capital IQ expected a loss of $0.33. The company did not report any revenue for the quarter ended Dec. 31 compared with $140,000 a year...
Myriad Genetics Gets US Patent for SneakPeek Snap Device
Myriad Genetics Gets US Patent for SneakPeek Snap Device
Mar 20, 2024
04:42 PM EDT, 03/20/2024 (MT Newswires) -- Myriad Genetics ( MYGN ) said late Wednesday the US Patent and Trademark Office granted it a patent covering the use of its blood-collection devices to determine fetal sex. The patent protects the company's SneakPeek Snap products in the country through at least 2040, Myriad said, and it also covers technology to improve...
Copyright 2023-2025 - www.financetom.com All Rights Reserved